Lower limbs are the hardest to treat with narrowband-UVB therapy on patients with chronic plaque psoriasis.

Psoriasis patients being treated with acitretin are at a greater risk of developing psychiatric disorders.

Psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer.

At the American Academy of Dermatology (AAD) annual meeting in New Orleans, research findings that showed systemic treatment of psoriasis...

Psoriasis patients reported that application feel, non-staining quality and quick absorption were important in topical treatments

A U.S. study has found that less than half of psoriasis patients report frequently engaging in shared decision-making with their...

Guselkumab does not increase cancer risk in psoriasis patients compared to general and psoriasis populations.

Risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17 inhibitors.